Company Filing History:
Years Active: 2011-2013
Title: The Innovative Contributions of Adrienne M Landry-Bayle
Introduction
Adrienne M Landry-Bayle is a prominent inventor based in Carlsbad, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target leukotriene Ahydrolase (LTAH). With a total of 6 patents to her name, her work has the potential to impact the treatment of various diseases and disorders.
Latest Patents
Adrienne's latest patents include groundbreaking innovations such as compounds with two fused bicyclic heteroaryl moieties. These compounds are designed for use as pharmaceutical compositions and methods for treating diseases mediated by LTAH. Another notable patent involves aryl-substituted bridged or fused diamine compounds, which also serve as pharmaceutical compositions for LTAH modulation. These inventions aim to address conditions such as allergy, asthma, autoimmune diseases, inflammatory bowel disease, and cardiovascular diseases.
Career Highlights
Adrienne is currently associated with Janssen Pharmaceutica NV, where she continues to advance her research and development efforts. Her work is characterized by a commitment to improving therapeutic options for patients suffering from complex health issues.
Collaborations
Throughout her career, Adrienne has collaborated with esteemed colleagues, including Laurent Gomez and Cheryl A Grice. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.
Conclusion
Adrienne M Landry-Bayle's contributions to the pharmaceutical industry exemplify the impact of innovative thinking in addressing critical health challenges. Her patents and ongoing research continue to pave the way for advancements in medical treatments.